Search results - Biochemia Medica

SEARCH FOR ARTICLES

Enter your keywords monitoring

Add to filter

Additional filters Number of results: 20

Article title

Add to filter

Article keywords

Add to filter

Volumes

Add to filter

Author

Add to filter

Country

Add to filter

Year of publishing

Add to filter

Type of the article

Add to filter

Development and validation of a HPLC method for therapeutic monitoring of brivaracetam

Sven Komljenović, Sara Zovko, Andreja Bujan Kovač, Željka Petelin Gadže, Miranda Sertić, Mila Lovrić

Original articles, Volume 36, Articles ahead of print

KEYWORDS: method validation; liquid chromatography; brivaracetam; therapeutic drug monitoring

https://doi.org/10.11613/BM.2026.020702

Key incidents identified by the Royal College of Pathologists of Australasia Quality Assurance Programs Key Incident Monitoring and Management EQA program

Anushka Jayanetti, David Roxby, Tony Badrick

Original articles, Volume 36, February, Issue 1

KEYWORDS: preanalytical phase; incident reporting; risks management; quality improvements; Benchmarking

https://doi.org/10.11613/BM.2026.010701

Use of Hoteling’s T multivariate control chart for effective monitoring of a laboratory test with a 3-level quality control scheme

Cristiano Ialongo

Original articles, Volume 35, June, Issue 2

KEYWORDS: quality control; analytical performance specification; multivariate analysis; analytical process

https://doi.org/10.11613/BM.2025.020701

Prediction interval: A powerful statistical tool for monitoring patients and analytical systems

Abdurrahman Coskun

Lessons in biostatistics, Volume 34, June, Issue 2

KEYWORDS: analytical performance; monitoring; personalized reference interval; prediction interval; reference change value

https://doi.org/10.11613/BM.2024.020101

Association of smoking cigarettes, age, and sex with serum concentrations of olanzapine in patients with schizophrenia

Mihovil Horvat, Mate Kadija, Andrijana Ščavničar, Maja Živković, Marina Šagud, Mila Lovrić

Original articles, Volume 33, October, Issue 3

KEYWORDS: central nervous system diseases; olanzapine; smoking; therapeutic drug monitoring

https://doi.org/10.11613/BM.2023.030702

Review of current incidents and risk calculations used in the Royal College of Australasian Pathologists Key Incident Management and Monitoring Systems - a system that could be used by all Australasian medical laboratories, and easily adapted to worldwide use

Stephanie Gay, Belinda Pope, Tony Badrick, Michael Whiley

Original articles, Volume 32, February, Issue 1

KEYWORDS: extra-analytical phase; laboratory organisation and management; pre- and post-analytical incidents; risk matrix; quality assurance

https://doi.org/10.11613/BM.2022.010702

Survey on request form content and result reporting in therapeutic drug monitoring service among laboratories in Czechia and Slovakia

Tomáš Šálek, Petr Schneiderka, Barbora Studená, Michaela Votroubková

Original Articles, Volume 30, June, Issue 2

KEYWORDS: drug monitoring; pharmacokinetics; preanalytical phase; clinical laboratory services; kidney function tests

https://doi.org/10.11613/BM.2020.020706

Changes in error rates in the Australian key incident monitoring and management system program

Stephanie Gay, Tony Badrick

Original papers, Volume 30, June, Issue 2

KEYWORDS: preanalytical errors; postanalytical errors; preanalytical risk; postanalytical risk

https://doi.org/10.11613/BM.2020.020704

European survey on preanalytical sample handling – Part 2: Practices of European laboratories on monitoring and processing haemolytic, icteric and lipemic samples. On behalf of the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) Working Group for the Preanalytical Phase (WG-PRE)

Janne Cadamuro, Giuseppe Lippi, Alexander von Meyer, Mercedes Ibarz, Edmee van Dongen, Michael Cornes, Mads Nybo, Pieter Vermeersch, Kjell Grankvist, Joao Tiago Guimaraes, Gunn B.B. Kristensen, Barbara de la Salle, Ana-Maria Simundic

Original Articles, Volume 29, June, Issue 2

KEYWORDS: preanalytics; standardization; survey

https://doi.org/10.11613/BM.2019.020705

Appropriateness of digoxin measurement in hospitalized patients

Seyma Oncu, Ayse Gelal, Ozgur Aslan, Reyhan S Ucku

Short Communications, Volume 28, February, Issue 1

KEYWORDS: digoxin; therapeutic drug monitoring; heart failure; electronic health records

https://doi.org/10.11613/BM.2018.010901

A model for managing and monitoring the quality of glucometers used in a high-volume clinical setting

Güzin Aykal, Ayşenur Yegin, Özgür Tekeli, Necat Yilmaz

Original paper, Volume 26, June, Issue 2

KEYWORDS: point-of-care testing (POCT); quality management program for glucometers; high-volume clinical setting; ISO 15197

https://doi.org/10.11613/BM.2016.022

Ten years of preanalytical monitoring and control: Synthetic Balanced Score Card Indicator

Maria Salinas, Maite López-Garrigós, Emilio Flores, Ana Santo-Quiles, Mercedes Gutierrez, Javier Lugo, Rosa Lillo, Carlos Leiva-Salinas

Original papers, Volume 25, February, Issue 1

KEYWORDS: Preanalytical phase; errors in laboratory medicine; balanced scorecard; patient safety

https://doi.org/10.11613/BM.2015.005

Clinical and diagnostic utility of saliva as a non-invasive diagnostic fluid: a systematic review

Lazaro Alessandro Soares Nunes, Sayeeda Mussavira, Omana Sukumaran Bindhu

Review Article, Volume 25, June, Issue 2

KEYWORDS: saliva; non-invasive; biological markers; drug monitoring; oral health

https://doi.org/10.11613/BM.2015.018

Comparison of digoxin concentration in plastic serum tubes with clot activator and heparinized plasma tubes

Lora Dukić, Ana-Maria Šimundić, Davorin Malogorski

Original papers, Volume 24, February, Issue 1

KEYWORDS: therapeutic drug monitoring; digoxin; evaluation; specimen collection; serum; plasma

https://doi.org/10.11613/BM.2014.016

Comparison between the immunoassay and high performance liquid chromatography for therapeutic monitoring of carbamazepine and phenytoine

Shaip Krasniqi, Markus Zeitlinger, Steffen Bauer

Original papers, Volume 20, October, Issue 3

KEYWORDS: carbamazepine; phenytoine; HPLC; immunoassay

https://doi.org/10.11613/BM.2010.044

Analytical validation of therapeutic drug monitoring (TDM) on AxSYM Abbott analyzer

Nora Nikolac, Ana-Maria Simundic, Nada Vukelic, Dalja Papic Futac, Nada Vrkic

Original papers, Volume 20, June, Issue 2

KEYWORDS: analytical validation; measurement uncertainty; valproic acid; phenobarbital; carbamazepine; theophylline

https://doi.org/10.11613/BM.2010.032

Monitoring chronic myeloid leukemia patients responding to treatment with tyrosine kinase inhibitors by real-time quantitative polymerase chain reaction

Margareta Radić Antolic, Renata Zadro, Dubravka Sertić, Boris Labar

Original papers, Volume 19, February, Issue 1

KEYWORDS: chronic myeloid leukemia; imatinib mesylate; quantitative polymerase chain reaction; major molecular response

https://doi.org/10.11613/BM.2009.006

Accu Chek Compact Plus blood glucometer evaluation

Jelena Kozar, Ana-Maria Simundic, Nora Nikolac, Marijana Žirović, Elizabeta Topić

Original papers, Volume 18, October, Issue 3

KEYWORDS: accuracy; precision; analytical evaluation; self monitoring blood glucose device; Bland-Altman; Clarke Error Grid analysis

https://doi.org/10.11613/BM.2008.032

Some important aspects of implementing tandem mass spectrometry

Christoph Seger, Andrea Griesmacher

Review, Volume 17, June, Issue 1

KEYWORDS: tandem mass spectrometry; targeted analysis; therapeutic drug monitoring; routine analysis; high performance liquid chromatography; HPLC-MS/MS

https://doi.org/10.11613/BM.2007.004

Platelet count monitoring in burn patients

Marina Pavić, Lara Milevoj

Original papers, Volume 17, December, Issue 2

KEYWORDS: platelet; burn patient; total body surface area percentage; disease outcome

https://doi.org/10.11613/BM.2007.021

SEARCH FOR ARTICLES

Development and validation of a HPLC method for therapeutic monitoring of brivaracetam

Key incidents identified by the Royal College of Pathologists of Australasia Quality Assurance Programs Key Incident Monitoring and Management EQA program

Use of Hoteling’s T multivariate control chart for effective monitoring of a laboratory test with a 3-level quality control scheme

Prediction interval: A powerful statistical tool for monitoring patients and analytical systems

Association of smoking cigarettes, age, and sex with serum concentrations of olanzapine in patients with schizophrenia

Review of current incidents and risk calculations used in the Royal College of Australasian Pathologists Key Incident Management and Monitoring Systems - a system that could be used by all Australasian medical laboratories, and easily adapted to worldwide use

Survey on request form content and result reporting in therapeutic drug monitoring service among laboratories in Czechia and Slovakia

Changes in error rates in the Australian key incident monitoring and management system program

Appropriateness of digoxin measurement in hospitalized patients

A model for managing and monitoring the quality of glucometers used in a high-volume clinical setting

Ten years of preanalytical monitoring and control: Synthetic Balanced Score Card Indicator

Clinical and diagnostic utility of saliva as a non-invasive diagnostic fluid: a systematic review

Comparison of digoxin concentration in plastic serum tubes with clot activator and heparinized plasma tubes

Comparison between the immunoassay and high performance liquid chromatography for therapeutic monitoring of carbamazepine and phenytoine

Analytical validation of therapeutic drug monitoring (TDM) on AxSYM Abbott analyzer

Monitoring chronic myeloid leukemia patients responding to treatment with tyrosine kinase inhibitors by real-time quantitative polymerase chain reaction

Accu Chek Compact Plus blood glucometer evaluation

Some important aspects of implementing tandem mass spectrometry

Platelet count monitoring in burn patients

MOST CITED ARTICLES

MOST DOWNLOADED ARTICLES

MOST VIEWED ARTICLES

Useful links